Tetrahydroisoquinoline (THIQ) is a key structural component in many biologically active molecules including natural products and synthetic pharmaceuticals. Here, we report on the use of transition-metal mediated [2 + 2 + 2] cyclotrimerisation of alkynes to generate tricyclic THIQs with potential to selectively inhibit AKR1C3.
Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity
Bonanni D.;Daga M.;Oliaro-Bosso S.;Boschi D.;Lolli M. L.;
2019-01-01
Abstract
Tetrahydroisoquinoline (THIQ) is a key structural component in many biologically active molecules including natural products and synthetic pharmaceuticals. Here, we report on the use of transition-metal mediated [2 + 2 + 2] cyclotrimerisation of alkynes to generate tricyclic THIQs with potential to selectively inhibit AKR1C3.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Santos et al_MedChemComm 2019_open acces.pdf
Open Access dal 28/06/2020
Descrizione: bozza finale pre-referaggio
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
732.11 kB
Formato
Adobe PDF
|
732.11 kB | Adobe PDF | Visualizza/Apri |
|
reprint_KLAUS_berberina.pdf
Accesso riservato
Descrizione: versione dell'editore
Tipo di file:
PDF EDITORIALE
Dimensione
1.01 MB
Formato
Adobe PDF
|
1.01 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
